Cargando…
A novel biomarker NIFK-AS1 promotes hepatocellular carcinoma cell cycle progression through interaction with SRSF10
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common carcinomas all over the world, with high mortality and low survival rate. Notably, many studies have showed that a variety of molecules play vital roles in the progression of HCC. Therefore, it is urgent to find reliable biomarkers...
Autores principales: | Song, Huibin, Li, Wenjing, Guo, Sixuan, He, Zhentao, Liu, Shi, Duo, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459191/ https://www.ncbi.nlm.nih.gov/pubmed/36092356 http://dx.doi.org/10.21037/jgo-22-705 |
Ejemplares similares
-
The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression
por: Pan, Wen-An, et al.
Publicado: (2015) -
NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates
por: Tan, Lin, et al.
Publicado: (2023) -
The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation
por: Lin, Tsung-Chieh, et al.
Publicado: (2016) -
PTBP1 promotes hepatocellular carcinoma progression by regulating the skipping of exon 9 in NUMB pre-mRNA
por: He, Zhentao, et al.
Publicado: (2023) -
HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway
por: Xu, Yanan, et al.
Publicado: (2023)